Description :
Tenders for Supply Of Each Pfs/ Amp/vial Contains Ranibizumab Upto2.3 Mg/0.23ml (the Drug Should Be Dgci Approved For Diabetic Macular Oedema, Retinal Vein Occlusion, Proliferative Diabetic Retinopathy, Reti Nopathy Of Prematurity And Myopic Choroidal Neovascular Membrane) ]